Mariusz Kaniewski
CEO
Mariusz combines a background in the humanities and public relations with a strong focus on bioinformatics, guiding BoostLife’s mission at the intersection of science, communication, and innovation. Show more
AI-driven medical solutions
We bring artificial intelligence to healthcare by transforming biological data into real diagnostic insights.
Let’s identify opportunities togetherABOUT US
Team of specialists focused on healthcare solutions
BoostLife is a team of scientists, analysts, and developers turning complex biomedical data into practical healthcare solutions.
We specialize in small-scale bioinformatics projects-RNA, microRNA, and multi-omic data interpretation-delivering high-impact results for medical, biotech, and pharma partners.
Our strength lies in people. With deep expertise in computational biology,data science, and AI, we act as an agile extension of your team-helping you scale research, accelerate discovery, and make better decisions, faster.
OUR MISSIONAI implementation to healthcare
Data science & AI
Development of unique RNA modeling platform that aids both RNA origami structures design and macromolecules interactions with emphasis on RNA:RNA binding to improve drug design and personalized medicine projects.
Big data analytics
Fight against pathogens using RNA-based solutions that employ AI methodology combined with nanostructure design.
Predictive analytics
Designing tailored AI-based algorithms to speed up biotech research and advance personalized medicine therapies development.
OUR TEAM
We are the trusted scientist experts
BoostLife was founded with a clear mission: to unite a team of top-tier researchers, scientists, and business strategists to push the boundaries of computational biology.
As a team of senior scientists, the intersection of deep science and artificial intelligence is our natural habitat. But what truly fuels our work is the success of our partners. We're committed to transforming cutting-edge innovation into measurable competitive advantages—accelerating discovery, enhancing precision, and unlocking breakthroughs in individualized healthcare.
Tomasz Olszewski
CTO
Tomasz combines knowledge about hardware with project managing skills to deliver projects on schedule and stay within the budget. Show more
Urszula Rogalla - Ładniak
Bioinformatician / Scientist
Urszula combines forensic genetics and bioinformatics, developing NGS methods for identification and diagnostics. Assistant Professor at NCU, R&D project manager, BoostLife.bio consultant. Show more
Jacek Mularski
Bioinformatician / Scientist
Jacek combines a background in chemistry and engineering with a strong focus on predictive molecular modeling, bridging theory and practice to accelerate discovery across pharmaceuticals, advanced materials, and beyond. Show more
Marcin Andrzej Woźniak
Bioinformatician / Scientist
Marcin combines a background in molecular genetics with advanced computational approaches, bridging biology and data science to advance diagnostics, forensics, and biotechnology. Show more
Waldemar Wiśniewski
Bussiness Development Manager
Waldemar builds strategic partnerships with research, biotech, and pharma sectors, fostering collaboration and growth of BoostLife’s bioinformatics initiatives. Show more
PORTFOLIOOmics
Microbial Genome Similarity Search with FASTQ (MGSS-FASTQ)
Project goal: Develop a tool to enable rapid identification of microorganism genomes from raw sequencing data generated by NGS/MPS and stored in FASTQ files, leveraging the RefSeqMasher algorithm but extending searches across the entire GenBank database, and providing online access through an intuitive web interface for query management. Show more
Chemistry
De novo Design and Synthesis of Selective Inhibitors for Carbonic Anhydrase Isoforms II, IX and XII
Project goal: Establish a de novo, structure-based workflow to design and synthesize small-molecule inhibitors selective for carbonic anhydrase isoforms II, IX, and XII, achieving nanomolar binding affinity and a novel mechanism distinct from known references. Show more
De novo Design of Dual mTOR/EGFR Inhibitor for a Double-Punch Effect
Project goal: Develop a single small molecule capable of selectively inhibiting both mTOR (serine-threonine kinase) and EGFR (tyrosine kinase) by identifying a shared structural motif that engages distinct active-site interactions, achieving a dual-target effect. Show more
